Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/04/2003US20030165896 Inhibitors of human plasmin derived from the kunitz domains
09/04/2003US20030165894 Methods and means for obtaining modified phenotypes
09/04/2003US20030165893 Comprises oligonucleotide for detection of vinyl chloride-decomposing bacterium; pollution control; bioremediation of earth or underground water polluted by chlorinated ethylene and/or chlorinated ethane
09/04/2003US20030165892 Unigene unidirectional antisense library
09/04/2003US20030165889 Identifying and detecting virulence determinant genes of Legionella pneumophila in cells; diagnosing infections
09/04/2003US20030165888 Detecting point mutations/single nucleotide polymorphisms; genetic disorders
09/04/2003US20030165885 Single primer PCR amplification of RNA
09/04/2003US20030165880 For detecting single nucleotide polymorphisms (SNPs) in diploid organisms using modified nucleotides/residues
09/04/2003US20030165878 Novel compositions and methods in cancer associated with altered expression of MCM3AP
09/04/2003US20030165877 Genetically engineered expression vector, phagemid or pseudovirions which transforms bacteria via synthetic cell wall membrane protein; gene transfer; gene therapy
09/04/2003US20030165876 Using polypyrimidine oligonucleotides to isolate nucleotide sequence having oligopurine-oligopyrimidine sequences
09/04/2003US20030165875 Novel receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
09/04/2003US20030165874 Nucleotide sequences probes for diagnosing and treating seizure disorders; restriction fragment length polymorphisms
09/04/2003US20030165873 For isolating ligand binding polypeptides; fusion proteins; drug screening; kits; surface plasmon resonance
09/04/2003US20030165872 Comprises nucleotide sequences coding protozoan parasite protein for diagnosis and prevention of infections; veterinary medicine; miticides; parasiticides; dog vaccine
09/04/2003US20030165865 Methods of analysis of nucleic acids
09/04/2003US20030165863 Comprises nucleotide sequences coding apoptosis polypeptides (NARC10/16) for use as tumor suppressor proteins and antitumor agents
09/04/2003US20030165862 Generating modified fly flippase recombination target sequences to act as site of genetic exchange during transposon-induced mutagenesis
09/04/2003US20030165861 Comprises kit for detection of single nucleotide polymorphisms, wherein reagents for complementary strand extension reaction and chemiluminescence are pretreated with pyrophosphatase and apyrase
09/04/2003US20030165860 Classifying and detection of campylobacter using VA1/R probes/primers to virulence determinant genes (VACA/VDG)
09/04/2003US20030165858 Novel GPCR-like proteins and nucleic acids encoding same
09/04/2003US20030165855 Methods for the analysis of non-proteinaceous components using a protease from a bacillus strain
09/04/2003US20030165848 Secreted Proteins and Nucleic Acids Encoding Them
09/04/2003US20030165843 Microarray for profiling gene expression in cells and tissues; antisense agents; antitumor agents
09/04/2003US20030165841 Use of phosphorothiolate polynucleotides in ligating nucleic acids
09/04/2003US20030165840 Comprises replication of oligonucleotides for detection, diagnosis and treatment of cancer using 5-Fluorouracil-based chemotherapeutic regimen
09/04/2003US20030165836 Using computer and allelic marker for mapping genetic disorder to preferential region on chromosome
09/04/2003US20030165834 Using colon cancer associated polypeptides (CCP) for diagnosing and detecting rectal tumors; immunoassays
09/04/2003US20030165833 Hybridization probes and oligonucleotides used for quantitative analysis fo ribosomal nucleic acids from yeast
09/04/2003US20030165832 Genetic replication of DNA contained in samples, then detecting and analyzing using fluorescent resonance energy transfer(FRET) hybridization probes, in kits; quantitative analysis
09/04/2003US20030165831 Comprise nucleotide sequences for diagnosing and treating gynecological tumors; antitumor/anticarcinogenic agents
09/04/2003US20030165826 PG-3 and biallelic markers thereof
09/04/2003US20030165825 Identifying oligopeptides using interaction-dependent enzyme activation system; high-throughput assay
09/04/2003US20030165820 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
09/04/2003US20030165818 Detecting modulators of serine protease/dipeptidyl peptidase activity for treating viral/muscular/bone/nervous system disorders
09/04/2003US20030165817 Diagnostic assay
09/04/2003US20030165814 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with CD antigens; animal husbandry
09/04/2003US20030165809 MARKs as modifiers of the p53 pathway and methods of use
09/04/2003US20030165807 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
09/04/2003US20030165567 Administering polypeptide by injection; gene therapy
09/04/2003US20030165558 Antiallergic agent
09/04/2003US20030165543 Transgenic plant-based vaccines
09/04/2003US20030165540 Sentinel virus II
09/04/2003US20030165539 Chimeric vaccine against tick-borne encephalitis virus
09/04/2003US20030165537 Vaccination against host cell-associated herpes viruses
09/04/2003US20030165535 Gag protein genes; reduced sensitivity
09/04/2003US20030165534 Modified DNA molecule, recombinant containing the same, and uses thereof
09/04/2003US20030165528 Streptococcus pyogenes antigens
09/04/2003US20030165521 Influenza vaccine
09/04/2003US20030165520 Attenuated forms of bovine viral diarrhea virus
09/04/2003US20030165514 Modulate immunology response
09/04/2003US20030165513 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
09/04/2003US20030165511 Protein-virus Complex; culture product; viricides
09/04/2003US20030165507 Postexposure prophylaxis therapy
09/04/2003US20030165506 Novel alpha-catenin expressed in heart and testis
09/04/2003US20030165501 Protein antagonist; insulin resistance; muscle disorders
09/04/2003US20030165497 RRP sequences and knockout mice and uses thereof
09/04/2003US20030165496 Alzheimer's disease
09/04/2003US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis
09/04/2003US20030165493 Antithrombin protein and DNA sequences from black fly
09/04/2003US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering
09/04/2003US20030165490 22196, a novel human aminopeptidase
09/04/2003US20030165488 Polypeptides; culture product
09/04/2003US20030165480 Using swine organs; controlling gene expression
09/04/2003US20030165478 Stabilized synthetic immunogen delivery system
09/04/2003US20030165477 Poxvirus with targeted infection specificity
09/04/2003US20030165476 Macroaggregated protein conjugates as oral genetic immunization delivery agents
09/04/2003US20030165469 Construction of high efficiency retroviral vector for gene therapy of hunter syndrome
09/04/2003US20030165468 Regulated vectors for controlling DNA hypermutability in eukaryotic cells
09/04/2003US20030165466 Recombinant poliovirus for the treatment of cancer
09/04/2003US20030165464 In vivo stimulation of angiogenic activity
09/04/2003US20030165463 Enhanced system for construction of adenovirus vectors
09/04/2003US20030165462 Deleted adenovirus vectors and methods of making and administering the same
09/04/2003US20030165459 Binding to tumor necrosis factor
09/04/2003US20030165434 Delivery of polynucleotide agents to the central nervous system
09/04/2003US20030165430 Transgenic fatty acid transport one (FATP1) non-human knockout mammals uses thereof
09/04/2003US20030165429 Method for measuring skin absorbability of a substance
09/04/2003CA2777599A1 A method of selectively producing male or female sterile plants
09/04/2003CA2743750A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus
09/04/2003CA2517027A1 Minicell compositions and methods
09/04/2003CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
09/04/2003CA2478475A1 Method for drying water-borne materials
09/04/2003CA2477632A1 Animal derived from manipulated embryo and preparing method thereof
09/04/2003CA2477624A1 Transgenic zebrafish models for thrombosis
09/04/2003CA2477574A1 Melting temperature dependent dna amplification
09/04/2003CA2477573A1 Headloop dna amplification
09/04/2003CA2477519A1 Method of error reduction in nucleic acid populations
09/04/2003CA2477503A1 Surface modification, linker attachment, and polymerization methods
09/04/2003CA2477409A1 Process for the preparation of hypoallergenic major birch pollen allergen rbet v 1
09/04/2003CA2477408A1 An obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
09/04/2003CA2477317A1 Holding tray having through-hole wells
09/04/2003CA2477295A1 Trans-splicing mediated imaging of gene expression
09/04/2003CA2477283A1 Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes
09/04/2003CA2477281A1 Method of using modified oligonucleotides for hepatic delivery
09/04/2003CA2477271A1 Nanostructures containing pilin protein
09/04/2003CA2477270A1 Nanostructures containing antibody assembly units
09/04/2003CA2477249A1 Novel type-1 cytokine receptor glm-r
09/04/2003CA2477243A1 Modified bace
09/04/2003CA2477239A1 Drug signatures
09/04/2003CA2477235A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
1 ... 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 ... 4023